Cardiome Pharma (CRME) Updates on Recent Insider Transactions; CEO, COO, Others Bought Shares

August 16, 2016 8:09 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Cardiome Pharma Corp. (Nasdaq: CRME) announces that Dr. William Hunter, President and CEO, Sheila Grant, Chief Operating Officer, David McMasters, General Counsel, David Dean, VP Business Development and Investor Relations, as well as a number of members of its Board of Directors, purchased an aggregate total of 108,813 common shares of Cardiome on both the TSX and the NASDAQ on August 11, 2016, August 12, 2016 and August 15, 2016. Details of the transactions can be found on the System for Electronic Disclosure by Insiders (SEDI). The purchases were made for investment purposes.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Insider Trades

Add Your Comment